Bionano Genomics (BNGO) Gross Profit (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Gross Profit data on file, last reported at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 10.69% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 165.55% YoY), and the FY2025 full-year result was $13.2 million, up 3369.74% from the prior year.
• Gross Profit retreated to $3.3 million in Q1 2026, from $3.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2024 to a low of -$8.4 million in Q3 2024.
• A 5-year average of $2.2 million and a median of $2.6 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 655.23% in 2022 and slumped 407.24% in 2024, its largest moves.
• Tracing BNGO's Gross Profit over 5 years: stood at $1.8 million in 2022, then soared by 35.07% to $2.4 million in 2023, then surged by 228.38% to $8.0 million in 2024, then tumbled by 57.54% to $3.4 million in 2025, then dropped by 4.32% to $3.3 million in 2026.
• Business Quant data shows BNGO's Gross Profit at $3.3 million in Q1 2026, $3.4 million in Q4 2025, and $3.4 million in Q3 2025.